Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5060)
All Articles published online
|
Publishing Process of This Article
|
Apr 27, 2023 (publication date) through Jun 16, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Surgery
ISSN
1948-9366
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Kumar A, Gautam V, Sandhu A, Rawat K, Sharma A, Saha L. Current and emerging therapeutic approaches for colorectal cancer: A comprehensive review. World J Gastrointest Surg 2023; 15(4): 495-519 [PMID: 37206081 DOI: 10.4240/wjgs.v15.i4.495] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v15/i4/495.htm |
| Number | Citing Articles |
| 1 |
Mary Garvey. Intestinal Dysbiosis: Microbial Imbalance Impacts on Colorectal Cancer Initiation, Progression and Disease Mitigation. Biomedicines 2024; 12(4): 740 doi: 10.3390/biomedicines12040740
|
| 2 |
Purvish M Parikh, Tarini P. Sahoo, Ghanashyam Biswas, Vineet Talwar, Somashekhar SP, Soumya Surath Panda, Avinash CB, Nishita Shetty, Anita Ramesh, Joydeep Ghosh, Vijith Vital Shetty, Radheshyam Naik, Ashish Singh, Gaurav Gupta, Bhavesh Parekh. Practical Consensus Guidelines for the Use of S-1 in GI Malignancies. South Asian Journal of Cancer 2024; 13(01): 077 doi: 10.1055/s-0043-1778685
|
| 3 |
Taxiarchis Konstantinos Nikolouzakis, Emmanuel Chrysos, Anca Oana Docea, Persefoni Fragkiadaki, John Souglakos, John Tsiaoussis, Aristidis Tsatsakis. Current and Future Trends of Colorectal Cancer Treatment: Exploring Advances in Immunotherapy. Cancers 2024; 16(11): 1995 doi: 10.3390/cancers16111995
|
| 4 |
Pablo Garrido, Adrián Casas-Benito, Ignacio M. Larrayoz, Judit Narro-Íñiguez, Susana Rubio-Mediavilla, Enrique Zozaya, Alfonso Martín-Carnicero, Alfredo Martínez. Expression of Mitochondrial Long Non-Coding RNAs, MDL1 and MDL1AS, Are Good Prognostic and/or Diagnostic Biomarkers for Several Cancers, Including Colorectal Cancer. Cancers 2024; 16(5): 960 doi: 10.3390/cancers16050960
|
| 5 |
Babak Arjmand, Sepideh Alavi-Moghadam, Zahra Faraji, Morteza Aghajanpoor-Pasha, Hasan Jalaeikhoo, Mohsen Rajaeinejad, Mohsen Nikandish, Ali Faridfar, Ahmad Rezazadeh-Mafi, Mostafa Rezaei-Tavirani, Arsalan Irompour. . Advances in Experimental Medicine and Biology 2024; doi: 10.1007/5584_2024_803
|
| 6 |
Soukaina Benmokhtar, Abdelilah Laraqui, Farida Hilali, Tahar Bajjou, Sara El Zaitouni, Meryem Jafari, Walid Baba, Hicham Elannaz, Idriss Amine Lahlou, Chahdi Hafsa, Mohamed Oukabli, Tarik Mahfoud, Rachid Tanz, Mohamed Ichou, Khaled Ennibi, Nadia Dakka, Yassine Sekhsokh. RAS/RAF/MAPK Pathway Mutations as Predictive Biomarkers in Middle Eastern Colorectal Cancer: A Systematic Review. Clinical Medicine Insights: Oncology 2024; 18 doi: 10.1177/11795549241255651
|
| 7 |
Hendra Susanto, Sa'diyatul Rizqie Amaliyah Firdaus, Moch Sholeh, Agustina Tri Endharti, Ahmad Taufiq, Nik Ahmad Nizam Nik Malek, Happy Kurnia Permatasari. Moringa oleifera Leaf Powder – Silver Nanoparticles (MOLP-AgNPs) efficiently inhibit metastasis and proliferative signaling in HT-29 human colorectal cancer cells. Journal of Agriculture and Food Research 2024; 16: 101149 doi: 10.1016/j.jafr.2024.101149
|
| 8 |
Pengju Yao, Mingjie Gao, Weiyi Hu, Jiahao Wang, Yuhao Wang, Qingsong Wang, Jianguo Ji. Proteogenomic analysis identifies neoantigens and bacterial peptides as immunotherapy targets in colorectal cancer. Pharmacological Research 2024; 204: 107209 doi: 10.1016/j.phrs.2024.107209
|
| 9 |
Afza Ahmad, Rohit Kumar Tiwari, Saleha Siddiqui, Muskan Chadha, Ratnakar Shukla, Vivek Srivastava. Targeting Signaling Pathways in Solid Tumors - Part A. International Review of Cell and Molecular Biology 2024; 385: 41 doi: 10.1016/bs.ircmb.2023.11.006
|
| 10 |
涵静 丁. Recent Advancements on the Anti-Tumor Small Molecule Inhibitors Targeting the p53-MDM2 Interaction. Advances in Clinical Medicine 2023; 13(08): 13474 doi: 10.12677/ACM.2023.1381881
|
| 11 |
Lena Van Dingenen, Charlotte Segers, Shari Wouters, Mohamed Mysara, Natalie Leys, Samir Kumar-Singh, Surbhi Malhotra-Kumar, Rob Van Houdt. Dissecting the role of the gut microbiome and fecal microbiota transplantation in radio- and immunotherapy treatment of colorectal cancer. Frontiers in Cellular and Infection Microbiology 2023; 13 doi: 10.3389/fcimb.2023.1298264
|
| 12 |
Huwei Nie, Jie Zhang, Yang Ai, Ailin Chen, Yuxi Li, Lin Zhang. Development and validation of prognostic nomograms for overall survival in patients with locally advanced colorectal cancer. Alexandria Engineering Journal 2024; 87: 308 doi: 10.1016/j.aej.2023.12.040
|
| 13 |
Riley M. Whalen, Ashley N. Anderson, Jocelyn A. Jones, Zachary Sims, Young Hwan Chang, Michel A. Nederlof, Melissa H. Wong, Summer L. Gibbs. Ultra high content analyses of circulating and tumor associated hybrid cells reveal phenotypic heterogeneity. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-57381-8
|
| 14 |
Sushma S. Kumar, Ashna Fathima, Preeti Srihari, Trinath Jamma. Host-gut microbiota derived secondary metabolite mediated regulation of Wnt/β-catenin pathway: a potential therapeutic axis in IBD and CRC. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1392565
|
| 15 |
Bin Jiang, Hongjian Zhou, Xingwang Xie, Tian Xia, Chao Ke. Down-regulation of zinc finger protein 335 undermines natural killer cell function in mouse colitis-associated colorectal carcinoma. Heliyon 2024; 10(4): e25721 doi: 10.1016/j.heliyon.2024.e25721
|
| 16 |
Yiping Zhang, Jun Xie. Targeting ferroptosis regulators by natural products in colorectal cancer. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1374722
|
| 17 |
Francesco Gervasi, Fanny Pojero. Use of Oleuropein and Hydroxytyrosol for Cancer Prevention and Treatment: Considerations about How Bioavailability and Metabolism Impact Their Adoption in Clinical Routine. Biomedicines 2024; 12(3): 502 doi: 10.3390/biomedicines12030502
|
| 18 |
Marcel Madej, Joanna Gola, Elwira Chrobak. Synthesis, Pharmacological Properties, and Potential Molecular Mechanisms of Antitumor Activity of Betulin and Its Derivatives in Gastrointestinal Cancers. Pharmaceutics 2023; 15(12): 2768 doi: 10.3390/pharmaceutics15122768
|
| 19 |
Duogang Xu, Yulei He, Changkang Liao, Jing Tan. Combining KRAS gene status with preoperative D‑dimer levels as a predictive marker of venous thromboembolism risk in patients with resectable colorectal cancer: A prospective cohort study. Biomedical Reports 2024; 20(6) doi: 10.3892/br.2024.1784
|
| 20 |
Shiliang Cheng, Meng Li, Chunguang Li, Yonggang Dai, Jinhua Zhuo, Jue Wang, Jingrong Qian, Zhihao Hao. JAML inhibits colorectal carcinogenesis by modulating the tumor immune microenvironment. In Vitro Cellular & Developmental Biology - Animal 2024; 60(4): 382 doi: 10.1007/s11626-024-00881-8
|
| 21 |
Maxim Girod, Anja Geisler, Luisa Hinze, Leslie Elsner, Babette Dieringer, Antje Beling, Jens Kurreck, Henry Fechner. Combination of FOLFOXIRI Drugs with Oncolytic Coxsackie B3 Virus PD-H Synergistically Induces Oncolysis in the Refractory Colorectal Cancer Cell Line Colo320. International Journal of Molecular Sciences 2024; 25(11): 5618 doi: 10.3390/ijms25115618
|
| 22 |
Ashok Kumar, Anirudh Goyal. Emerging molecules, tools, technology, and future of surgical knife in gastroenterology. World Journal of Gastrointestinal Surgery 2024; 16(4): 988-998 doi: 10.4240/wjgs.v16.i4.988
|
| 23 |
Chiugo Okoye, My Tran, Elizabeth Soladoye, Darlington E Akahara, Chinemerem M Emeasoba, Blessing T Ojinna, Emmanuel Anasonye, Oyindamola O Obadare, Chiamaka S Diala, Bolanle H Salaudeen, Endurance O Evbayekha, Okelue E Okobi. A Review of 10-Year Survivability of Immunotherapy in the Management of Colon Cancer. Cureus 2023; doi: 10.7759/cureus.43189
|
| 24 |
Sezgin Zeren, Semih Seker, Gizem Akkaş Akgün, Emrah Okur, Azmi Yerlikaya. Label-free nLC-MS/MS proteomic analysis reveals significant differences in the proteome between colorectal cancer tissues and normal colon mucosa. Medical Oncology 2023; 40(10) doi: 10.1007/s12032-023-02173-9
|
| 25 |
Mariana Melo Moreira, Marta Carriço, Manuel Luís Capelas, Nuno Pimenta, Teresa Santos, Susana Ganhão-Arranhado, Antti Mäkitie, Paula Ravasco. The impact of pre-, pro- and synbiotics supplementation in colorectal cancer treatment: a systematic review. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1395966
|